Cytochrome P450 4F3 (CYP4F3) catalyzes the inactivation of leukotriene B 4 by -oxidation in human neutrophils. To understand the regulation of CYP4F3 expression, we analyzed the CYP4F3 gene and cloned a novel isoform (CYP4F3B) that is expressed in fetal and adult liver, but not in neutrophils. The CYP4F3 gene contains 14 exons and 13 introns. The cDNAs for CYP4F3A (the neutrophil isoform) and CYP4F3B have identical coding regions, except that they contain exons 4 and 3, respectively. Both exons code for amino acids 66 -114 but share only 27% identity. When expressed in COS-7 cells, the K m of CYP4F3B was determined to be 26-fold higher than the K m of CYP4F3A using leukotriene B 4 as a substrate. 5-Rapid amplification of cDNA end studies reveal that the CYP4F3A and CYP4F3B transcripts have 5-termini derived from different parts of the gene and are initiated from distinct transcription start sites located 519 and 71 base pairs (bp), respectively, from the ATG initiation codon. A consensus TATA box is located 27 bp upstream of the CYP4F3B transcription start site, and a TATA box-like sequence is located 23 bp upstream of the CYP4F3A transcription start site. The data indicate that the tissue-specific expression of functionally distinct CYP4F3 isoforms is regulated by alternative promoter usage and mutually exclusive exon splicing.
Leukotriene B 4 (LTB 4 )1 is synthesized from arachidonic acid by the sequential action of 5-lipoxygenase and leukotriene A 4 hydrolase enzymes in neutrophils, monocytes and macrophages (1). It is a potent chemoattractant for human neutrophils and also has chemotactic activity for monocytes (2-6). LTB 4 exerts this activity via a G protein-coupled receptor in target cells (7) and induces a cascade of cellular events that amplify the inflammatory response (8). The generation of LTB 4 is implicated in the pathogenesis of inflammatory disorders that involve prominent neutrophil infiltration of tissues (8, 9).Recently, it has been suggested that LTB 4 can also play an intracellular role in regulating transcription by functioning as a ligand for peroxisome proliferator-activated receptor ␣ (10). The bioactivity of LTB 4 is determined by the regulation and kinetic properties of the enzymes that control its synthesis and catabolism.LTB 4 is inactivated by -oxidation of its terminal carbon to yield 20-OH LTB 4 and 20-COOH LTB 4 (10, 11). The initial -hydroxylation is catalyzed by CYP4F3 (12-16), which by biochemical analysis has a restricted localization to neutrophils, and to a lesser extent monocytes (12, 17). The CYP4 family of enzymes catalyze the -hydroxylation of a large number of fatty acids and arachidonic acid derivatives (18). The CYP4F subfamily utilizes LTB 4 as a substrate. Two members of this subfamily have been identified in humans and are designated CYP4F3 (16, 19) and CYP4F2 (20). Studies of neutrophil microsomes or recombinant CYP4F3 have determined the specificity of CYP4F3 for LTB 4 (15, 21). CYP4F1, -4, -5, and -6 are designations given to rat enzymes (22, 23).The two human ...